5 Feb 2020 17:37
EUROPEAN OPPORTUNITIES TRUST PLC (the 'Company')
Legal Entity Identifier: 549300XN7RXQWHN18849
Month end portfolio information
All data is as at 31 January 2020
Top twenty holdings
Stock | Sector | Country of Listing | % of Total Assets (Incl Drawn down bank debt) |
Wirecard AG | Information Technology | Germany | 11.8% |
Novo Nordisk | Health Care | Denmark | 9.0% |
Relx | Industrials | Netherlands | 8.6% |
Experian | Industrials | United Kingdom | 7.9% |
Deutsche Boerse | Financials | Germany | 6.4% |
Intermediate Capital | Financials | United Kingdom | 5.7% |
Dassault Systemes | Information Technology | France | 5.2% |
Adidas | Consumer Discretionary | Germany | 5.1% |
Grenke | Financials | Germany | 4.9% |
Biomerieux | Health Care | France | 4.7% |
Grifols | Health Care | Spain | 4.3% |
Carnival | Consumer Discretionary | United States | 4.0% |
Amadeus IT | Information Technology | Spain | 3.9% |
Edenred | Information Technology | France | 3.2% |
Genus | Health Care | United Kingdom | 2.6% |
Bayer | Health Care | Germany | 1.9% |
Arrow Global Group | Financials | United Kingdom | 1.8% |
Barry Callebaut | Consumer Staples | Switzerland | 1.4% |
Ubisoft Entertainment | Communication Services | France | 1.3% |
Infineon Technologies | Information Technology | Germany | 1.0% |
Country of listing of investee companies
| % of total assets (including drawn down bank debt) |
Germany | 31.5% |
United Kingdom | 18.6% |
France | 15.9% |
Denmark | 9.5% |
Netherlands | 8.8% |
Spain | 8.2% |
United States | 4.0% |
Switzerland | 1.4% |
Finland | 1.0% |
Italy | 0.6% |
Sweden | 0.4% |
Market Capitalisation of investee companies
| % of Total Assets (including Drawn down bank debt) |
Large | 87.2% |
Mid | 10.2% |
Small | 2.5% |
The Company's most recent report and accounts and further information for shareholders is published on the Company's website at www.europeanopportunitiestrust.com
Enquiries:
Devon Equity Management Limited,
Company Secretaries to European Opportunities Trust PLC
Richard Pavry
020 3985 0441
enquiries@devonem.com
5 February 2020